ConductScience.org, home

Paper8556519

Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.

Osiowy C and 2 others. Clin Diagn Lab Immunol, 1994. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants. Papers, record 8556519. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8556519

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.
PubMed
Journal
Clin Diagn Lab Immunol
PubMed
Year
1994
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2021-05-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Osiowy CC
2Horne DD
3Anderson RR

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Respiratory Syncytial Virus InfectionsMajor topic
Respiratory Syncytial Virus, HumanMajor topic
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Viral
Child
Child, Preschool
Humans
Indicator Dilution Techniques
Infant
Laryngeal Neoplasms
Middle Aged
Neutralization Tests
Precipitin Tests
Receptors, Fc
Tumor Cells, Cultured
Viral Envelope Proteins

Source PubMed

Download CSV of topics

References48

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12035517Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life.Am J Epidemiol1991https://conductscience.org/library/papers/2035517PubMed
22010624Immunity to and frequency of reinfection with respiratory syncytial virus.J Infect Dis1991https://conductscience.org/library/papers/2010624PubMed
31680925Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors.J Immunol1991https://conductscience.org/library/papers/1680925PubMed
41659798A study on the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies.Arch Virol1991https://conductscience.org/library/papers/1659798PubMed
51753101Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.J Immunol1991https://conductscience.org/library/papers/1753101PubMed
61370367Antibody-dependent enhancement of hantavirus infection in macrophage cell lines.Arch Virol1992https://conductscience.org/library/papers/1370367PubMed
71550681Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and bronchoalveolar macrophages.Am J Respir Cell Mol Biol1992https://conductscience.org/library/papers/1550681PubMed
81554223Respiratory syncytial virus infection of alveolar macrophages in adult transplant patients.Am Rev Respir Dis1992https://conductscience.org/library/papers/1554223PubMed
91564451Infection enhancement of influenza A NWS virus in primary murine macrophages by anti-hemagglutinin monoclonal antibody.J Med Virol1992https://conductscience.org/library/papers/1564451PubMed
101315492Effect of macrophages and in vitro infection with parainfluenza type 3 and respiratory syncytial viruses on the mitogenic response of bovine lymphocytes.Am J Vet Res1992https://conductscience.org/library/papers/1315492PubMed
118496762Respiratory syncytial virus-specific immunoglobulins in preterm infants.J Pediatr1993https://conductscience.org/library/papers/8496762PubMed
128413475Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group.N Engl J Med1993https://conductscience.org/library/papers/8413475PubMed
138024304Severity of respiratory syncytial virus infections and immunoglobulin concentrations.Arch Dis Child1993https://conductscience.org/library/papers/8024304PubMed
144981688Differences in anti-protein A activity among IgG subgroups.J Immunol1969https://conductscience.org/library/papers/4981688PubMed
154355170Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.Am J Epidemiol1973https://conductscience.org/library/papers/4355170PubMed
16977992Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus.J Infect Dis1976https://conductscience.org/library/papers/977992PubMed
177365579The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses.J Pediatr1980https://conductscience.org/library/papers/7365579PubMed
187000905Characterization of the Fc receptor for IgG on a human macrophage cell line, U937.J Immunol1980https://conductscience.org/library/papers/7000905PubMed
197229749Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level.J Pediatr1981https://conductscience.org/library/papers/7229749PubMed
207241656Respiratory syncytial virus proteins: identification by immunoprecipitation.J Virol1981https://conductscience.org/library/papers/7241656PubMed

See all 48 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
39910047A truncated pre-F protein mRNA vaccine elicits an enhanced immune response and protection against respiratory syncytial virus.Nat Commun2025https://conductscience.org/library/papers/39910047PubMed
39329969Analysis of Beyfortus® (Nirsevimab) Immunization Campaign: Effectiveness, Biases, and ADE Risks in RSV Prevention.Curr Issues Mol Biol2024https://conductscience.org/library/papers/39329969PubMed
37483779Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19.Heliyon2023https://conductscience.org/library/papers/37483779PubMed
36371813Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis.Mol Immunol2022https://conductscience.org/library/papers/36371813PubMed
30984626Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus.Front Cell Infect Microbiol2019https://conductscience.org/library/papers/30984626PubMed
30967872Fc-Mediated Antibody Effector Functions During Respiratory Syncytial Virus Infection and Disease.Front Immunol2019https://conductscience.org/library/papers/30967872PubMed
30252097Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector Function.J Infect Dis2019https://conductscience.org/library/papers/30252097PubMed
29768937Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus.Antivir Chem Chemother2018https://conductscience.org/library/papers/29768937PubMed
28794038In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants.J Virol2017https://conductscience.org/library/papers/28794038PubMed
27751627A Structural and Mathematical Modeling Analysis of the Likelihood of Antibody-Dependent Enhancement in Influenza.Trends Microbiol2016https://conductscience.org/library/papers/27751627PubMed
24227634Fc gamma receptors in respiratory syncytial virus infections: implications for innate immunity.Rev Med Virol2014https://conductscience.org/library/papers/24227634PubMed
21933386
Label-free quantitative proteomics reveals regulation of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) and 5'-3'-exoribonuclease 2 (XRN2) during respiratory syncytial virus infection.
Virol J2011https://conductscience.org/library/papers/21933386PubMed
18471342Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection.Expert Rev Mol Med2008https://conductscience.org/library/papers/18471342PubMed
9151809Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes.J Virol1997https://conductscience.org/library/papers/9151809PubMed
9007586Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.Infection1996https://conductscience.org/library/papers/9007586PubMed
8705669Neutralizing and enhancing activities of human respiratory syncytial virus-specific antibodies.Clin Diagn Lab Immunol1996https://conductscience.org/library/papers/8705669PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8556519

GET https://conductscience.org/api/papers/v1/8556519/references?page=2